Lead investors include Casdin Capital, Viking Global Investors and Ginkgo Bioworks
Chemical manufacturing company Genomatica has secured US$90m of equity investments following a drive to increase capital.
Participants include new lead investor . . .
This is a small extract of the full article which is available ONLY to premium content subscribers. Subscribers sign-in (top right) to read the article.
Subscribe now to premium content on Cosmetics Business